Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.00    -0.15 (-4.76%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.23m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading Update

24 Jun 2020 07:00

RNS Number : 8456Q
Tavistock Investments PLC
24 June 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

24 June 2020

The Company is pleased to update the market that trading during the first two months of the financial year has been ahead of the Board's expectations. This is due both to the swift action taken to mitigate the impact of COVID-19 and the performance of the Tavistock ACUMEN Protection Portfolios.

Rapid adoption of new technology-based work practices, and implementation of business continuity plans, enabled the entire Group to move to home-based working while cost reductions were made. Voluntary salary waivers by all senior management and the significant majority of other staff, together with use of the Government's furlough scheme, mean the company has continued to trade profitably during lockdown.

The strong performance of Tavistock's ACUMEN Protection Portfolios has contributed significantly to this success. Designed specifically to shield clients from sharp and sustained falls in financial markets, they feature an automated algorithmic safeguard. If markets fall, as volatility increases, the algorithm triggers movement out of investment assets and into cash; when markets recover, as volatility decreases, the reverse is triggered, with cash being gradually reinvested into higher risk assets. These funds perform particularly well when used as a bond substitute within clients' investment portfolios.

The newest fund, the ACUMEN ESG Protection Portfolio, has performed particularly effectively since its launch on 5 December 2019, with its NAV (net asset value) having declined by less than 1%. Morgan Stanley & Co International Plc provides the ESG Protection Portfolio with its protection level, set at 90% of its NAV's highest ever value. This protection enables investors to both limit their downside exposure, and lock in 90% of performance upside.

Brian Raven, Chief Executive, said: "The performance of the ACUMEN Protection Portfolios has been exceptional, underpinning the profitability of the Group's investment management business. Our advisory business has also performed particularly well, stepping up to support clients in these challenging times and to mitigate the adverse effect that the lockdown is having on new business.

I have been enormously encouraged by the way that our entire workforce has risen to the challenges arising from the pandemic and by the widespread adoption of the Protection Portfolios to safeguard clients' personal wealth in these uncertain times.

The COVID-19 crisis triggered the biggest and fastest fall in markets since 1929 and we are now facing the worst recession in hundreds of years. Historically, viral pandemics have come in waves, so our Protection Portfolios seem to be the ideal choice right now, for the many retail clients worried about further, severe market shocks.

The Board maintains its focus on tight financial management and is confident the business will emerge from the current crisis in good shape."

Ends

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Sophie Paterson

Tel: 07540 496 159

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEERSIVFII
Date   Source Headline
11th Mar 20217:00 amRNSRescheduling of General Meeting
1st Mar 20217:00 amRNSNotice of GM
10th Feb 202112:01 pmRNSLetter to shareholders
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:00 pmRNSPrice Monitoring Extension
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSDirector/PDMR Shareholding
4th Dec 20207:00 amRNSPostponement of general meeting
20th Nov 20207:00 amRNSNotice of GM
10th Nov 20207:00 amRNSInterim Results
23rd Sep 202012:15 pmRNSResult of AGM & GM
14th Sep 20207:00 amRNSCorrection to no. of shares admitted to trading
9th Sep 20207:00 amRNSAppointment of Nominated Adviser & Rule 17 update
28th Aug 20207:00 amRNSNotice of AGM
23rd Jul 20209:07 amRNSFinal Results For Year Ended 31 March 2020
23rd Jul 20207:00 amRNSFinal Results For Year Ended 31 March 2020
24th Jun 20207:00 amRNSTrading Update
8th Apr 20207:00 amRNSTrading Update
19th Mar 202010:52 amRNSDirector/PDMR Shareholding
19th Mar 202010:01 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSIssue of Shares to Strategic Investor
21st Nov 20197:00 amRNSInterim Results
1st Oct 20194:35 pmRNSDirector/PDMR Shareholding
30th Sep 201911:44 amRNSDirector/PDMR Shareholding
27th Sep 20196:09 pmRNSDirector/PDMR Shareholding
27th Sep 20197:00 amRNSTrading Update And Entry Into Loan Facility
25th Sep 20193:44 pmRNSResult of AGM
4th Sep 201912:11 pmRNSNotice of AGM
3rd Sep 20197:00 amRNSChange of Auditor
30th May 201911:49 amRNSTermination of Strategic Alliance with Lighthouse
15th May 20191:17 pmRNSPayment of Maiden Interim Dividend
15th May 20197:00 amRNSFinal Results
13th May 20197:00 amRNSNotice of results
9th May 20198:56 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSPre-Close Trading Update
23rd Nov 20187:00 amRNSHolding(s) in Company
23rd Nov 20187:00 amRNSHolding(s) in Company
19th Nov 20185:47 pmRNSHolding(s) in Company
14th Nov 20187:30 amRNSResult of £1.25m Fundraise
14th Nov 20187:00 amRNSStrategic Alliance and Proposed Fundraise
8th Nov 20185:29 pmRNSCorrection to Interim Results
8th Nov 20187:00 amRNSInterim Results
1st Oct 20184:26 pmRNSHolding(s) in Company
26th Sep 201812:35 pmRNSResult of AGM
30th Aug 20181:10 pmRNSNotice of AGM
27th Jul 201812:30 pmRNSHolding(s) in Company
19th Jul 20184:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.